These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34997212)
1. CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury. Zhang H; Kim H; Park BW; Noh M; Kim Y; Park J; Park JH; Kim JJ; Sim WS; Ban K; Park HJ; Kwon YG Exp Mol Med; 2022 Jan; 54(1):23-34. PubMed ID: 34997212 [TBL] [Abstract][Full Text] [Related]
2. CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury. Kim DY; Zhang H; Park S; Kim Y; Bae CR; Kim YM; Kwon YG J Mol Med (Berl); 2020 Jun; 98(6):875-886. PubMed ID: 32415357 [TBL] [Abstract][Full Text] [Related]
3. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury. Chen G; Xu C; Gillette TG; Huang T; Huang P; Li Q; Li X; Li Q; Ning Y; Tang R; Huang C; Xiong Y; Tian X; Xu J; Xu J; Chang L; Wei C; Jin C; Hill JA; Yang Y Theranostics; 2020; 10(25):11754-11774. PubMed ID: 33052245 [No Abstract] [Full Text] [Related]
4. Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model. Kim H; Noh M; Zhang H; Kim Y; Park S; Park J; Kwon YG Fluids Barriers CNS; 2023 Feb; 20(1):9. PubMed ID: 36726154 [TBL] [Abstract][Full Text] [Related]
5. CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice. Bae CR; Kim Y; Kwon YG J Pharmacol Sci; 2024 Feb; 154(2):77-85. PubMed ID: 38246731 [TBL] [Abstract][Full Text] [Related]
6. Implication of IGF1R signaling in the protective effect of Astragaloside IV on ischemia and reperfusion-induced cardiac microvascular endothelial hyperpermeability. He K; Yan L; Lin SQ; Liu YY; Hu BH; Chang X; Zhao XR; He SY; Wei XH; Fan JY; Pan CS; Han JY Phytomedicine; 2022 Jun; 100():154045. PubMed ID: 35338991 [TBL] [Abstract][Full Text] [Related]
7. Oxycodone protects cardiac microvascular endothelial cells against ischemia/reperfusion injury by binding to Sigma-1 Receptor. Ji M; Cheng J; Zhang D Bioengineered; 2022 Apr; 13(4):9628-9644. PubMed ID: 35412431 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of HINT2 on mitochondrial function via repressing MCU complex activation attenuates cardiac microvascular ischemia-reperfusion injury. Li S; Chen J; Liu M; Chen Y; Wu Y; Li Q; Ma T; Gao J; Xia Y; Fan M; Chen A; Lu D; Su E; Xu F; Chen Z; Qian J; Ge J Basic Res Cardiol; 2021 Dec; 116(1):65. PubMed ID: 34914018 [TBL] [Abstract][Full Text] [Related]
9. Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury. Bai J; Wang Q; Qi J; Yu H; Wang C; Wang X; Ren Y; Yang F Phytomedicine; 2019 Oct; 63():153035. PubMed ID: 31377586 [TBL] [Abstract][Full Text] [Related]
10. Shear stress inhibits cardiac microvascular endothelial cells apoptosis to protect against myocardial ischemia reperfusion injury via YAP/miR-206/PDCD4 signaling pathway. Zhang Q; Cao Y; Liu Y; Huang W; Ren J; Wang P; Song C; Fan K; Ba L; Wang L; Sun H Biochem Pharmacol; 2021 Apr; 186():114466. PubMed ID: 33610591 [TBL] [Abstract][Full Text] [Related]
11. Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway. Cai C; Guo Z; Chang X; Li Z; Wu F; He J; Cao T; Wang K; Shi N; Zhou H; Toan S; Muid D; Tan Y Redox Biol; 2022 Jun; 52():102288. PubMed ID: 35325804 [TBL] [Abstract][Full Text] [Related]
12. Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats. Lin C; Sui H; Gu J; Yang X; Deng L; Li W; Ding W; Li D; Yang Y Microvasc Res; 2013 Nov; 90():162-8. PubMed ID: 23988878 [TBL] [Abstract][Full Text] [Related]
13. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the FoxO3a pathway in the ischemia/reperfusion injury of cardiac microvascular endothelial cells. Qi XF; Li YJ; Chen ZY; Kim SK; Lee KJ; Cai DQ Exp Mol Pathol; 2013 Oct; 95(2):242-7. PubMed ID: 23948278 [TBL] [Abstract][Full Text] [Related]
15. Role of GADD45A in myocardial ischemia/reperfusion through mediation of the JNK/p38 MAPK and STAT3/VEGF pathways. Wang Y; Gao H; Cao X; Li Z; Kuang Y; Ji Y; Li Y Int J Mol Med; 2022 Dec; 50(6):. PubMed ID: 36331027 [TBL] [Abstract][Full Text] [Related]
16. microRNA-30e up-regulation alleviates myocardial ischemia-reperfusion injury and promotes ventricular remodeling via SOX9 repression. Cheng N; Li L; Wu Y; Wang M; Yang M; Wei S; Wang R Mol Immunol; 2021 Feb; 130():96-103. PubMed ID: 33293097 [TBL] [Abstract][Full Text] [Related]
17. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury. Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659 [TBL] [Abstract][Full Text] [Related]
18. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury. Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431 [TBL] [Abstract][Full Text] [Related]